Literature DB >> 3215689

Murine typhus and spotted fever in Israel in the eighties: retrospective analysis.

Y Shaked1, Y Samra, M K Maeir, E Rubinstein.   

Abstract

One hundred and twenty-one cases of murine typhus and spotted fever in Israel between 1976 and 1985 in the Chaim Sheba Medical Center are reviewed. Clinical manifestations of murine typhus were similar to those described previously, but those of spotted fever were different from classical Mediterranean spotted fever: rash was present in 87% but eschar was noted in only two out of 38 patients. The occurrence of relapse in eight of the 16 patients treated with chloramphenicol (seven cases of murine typhus and one case of spotted fever) was striking, particularly since none occurred in 86 patients treated with tetracycline hydrochloride (p less than 0.01). Relapses were milder than the primary illness, except for one which did not receive specific therapy and was fatal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215689     DOI: 10.1007/bf01645073

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Murine typhus and spotted fever in Israel in the seventies.

Authors:  T Rosenthal; D Michaeli
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  An outbreak of tick typhus in the coastal plain of Israel. 13 cases from the Sharon area.

Authors:  A Gutman; H Schreiber; R Taragan
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

3.  Scrub typhus. A comparison of chloramphenicol and tetracycline in its treatment.

Authors:  T W Sheehy; D Hazlett; R E Turk
Journal:  Arch Intern Med       Date:  1973-07

4.  Coagulation abnormalities in patients with Mediterranean spotted fever.

Authors:  V Vicente; I Alberca; R Ruiz; I Herrero; R Gonzalez; J Portugal
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

Review 5.  Mediterranean spotted fever: a cooperative study of 227 cases.

Authors:  B Font-Creus; F Bella-Cueto; E Espejo-Arenas; R Vidal-Sanahuja; T Muñoz-Espin; M Nolla-Salas; A Casagran-Borrell; J Mercade-Cuesta; F Segura-Porta
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Hyponatremia in Rocky Mountain spotted fever: role of antidiuretic hormone.

Authors:  L G Kaplowitz; G L Robertson
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

7.  The isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from other members of the group by immunofluorescence methods.

Authors:  R A Goldwasser; Y Steiman; W Klingberg; T A Swartz; M A Klingberg
Journal:  Scand J Infect Dis       Date:  1974

8.  Rickettsiosis-associated hyponatremia.

Authors:  M Mouallem; E Friedman; R Pauzner; E Schwartz; E Rubinstein
Journal:  Infection       Date:  1987       Impact factor: 3.553

  8 in total
  12 in total

1.  Clinicoepidemiological study of murine typhus on the Greek island of Evia.

Authors:  Y Tselentis; T L Babalis; D Chrysanthis; A Gikas; G Chaliotis; D Raoult
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

Review 2.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  Serological examination of human and animal sera from six countries of three continents for the presence of rickettsial antibodies.

Authors:  E Kovácová; W Sixl; D Stünzner; J Urvölgyi; J Kazár
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 4.  Approaches to the molecular epidemiology of rickettsioses.

Authors:  N Balayeva
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

5.  High Morbidity Due to Murine Typhus Upsurge in Urban Neighborhoods in Central Israel.

Authors:  Evgeny Rogozin; Tsilia Lazarovitch; Miriam Weinberger
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

6.  The seroprevalence of ten zoonoses in two villages of Crete, Greece.

Authors:  M Antoniou; Y Tselentis; T Babalis; A Gikas; N Stratigakis; I Vlachonikolis; A Kafatos; M Fioretos
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

7.  In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers.

Authors:  T J Ives; P Manzewitsch; R L Regnery; J D Butts; M Kebede
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Murine typhus among Arabs and Jews in Israel 1991--2001.

Authors:  Jihad Bishara; Dov Hershkovitz; Pablo Yagupsky; Tzippy Lazarovitch; Ida Boldur; Tzippy Kra-Oz; Silvio Pitlik
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 9.  Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

10.  An Unusual Cutaneous Manifestation in a Patient with Murine Typhus.

Authors:  Lucas S Blanton; Alfred S Lea; Brent C Kelly; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.